๐Capturing Top 10 Ex_dividend: BKE, ABBV, PNC, MAA, ACN...
1. Which High Ex-dividend Stock (on 13 January ~ 17 January) do You Like the Most?
Be Sure To Check Out the Last Chance to Buy the Top 10 High dividend stocks going to Ex-dividends This Week: many companies like $Buckle(BKE)$ and $AbbVie(ABBV)$ showing below are about to give decent dividends into "your pocket".
Editor's notes:
A dividend-paying stock ex-dividend date, or ex-date, is very important to investors. In a nutshell, if you buy a dividend stock before the ex-dividend date, then you will receive the next upcoming dividend payment.
If you purchase the stock on or after the ex-dividend date, you will not receive the dividend. Some investors utilize strategies whereby they will purchase stocks just prior to an ex-dividend date and sell shortly thereafter.
2. YTD25 of the Above 10 Stocks are as Below:
According to data from TradingView, in 2025, companies such as $Accenture PLC(ACN)$ , $MSC Industrial Direct(MSM)$ , and $Quest Diagnostics(DGX)$ saw increases in their stock prices. In contrast, the stock prices for The $Buckle(BKE)$ , $AbbVie(ABBV)$ , The $PNC Financial Services Group Inc(PNC)$ , $Mid-America Apartment Communities(MAA)$ , $Universal(UVV)$ , $American(AFG)$ , and $City(CHCO)$ experienced declines.
3. Reply to Win Tiger Coins
Which stock above do you like the most? Why?
Please find the Analyst Price Target of the mentioned stocks from Tiger Trade "Analysis".
Any other companies going to ex_dividend this week you are interested in?
๐Prizes
๐ฏ All valid comment on the following post will receive 5 Tiger Coins.
๐ฏ The Top 3 comments with the most likes will get another 10 Tiger Coins.
A tool for SG Tigers that you can use to make your investments more efficient.
Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with upcoming 0-commission, unlimited trading on SG, HK, and US stocks, as well as ETFs. Find out more here.
Other helpful links:
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
@Aqa @rL @GoodLife99 @Universeๅฎๅฎ @HelenJanet @LMSunshine @koolgal @Shyon @SPACE ROCKET @TigerGPT
Which stock above do you like the most? Why?
Please find the Analyst Price Target of the mentioned stocks from Tiger Trade "Analysis".
Any other companies going to ex_dividend this week you are interested in?
๐Prizes
๐ฏ All valid comment on the following post will receive 5 Tiger Coins.
๐๐๐I like dividend stocks and even better if they are undervalued. AbbVie $AbbVie(ABBV)$
AbbVie is a pharmaceutical products company that is focused on immunology, oncology and neurological health.
The most important product for AbbVie is Humira which is a immunology drug used for treatment of rheumatoid arthritis. However its patent protection for Humira was lost in January 2023. Since then AbbVie has launched 2 new successful immunology medicines Skyrizi and Rinvoq which are performing very well.
AbbVie has recently announced an increase of 5.8% in its quarterly dividend for 2025. The current dividend yield is 3.71%. AbbVie will go ex dividend on January 15 2025 with a pay date of February 14 2025.
Wall Street Analysts are bullish on AbbVie with a Buy rating, Average Target price of USD 205.59, a upside potential of 16%.
I like AbbVie for its upside potential and great dividends which is an excellent source of passive income while waiting for capital growth.
@Tiger_Earnings @Tiger_comments @TigerClub
Quest has strong financial track record and is committed to returning value to shareholders through regular dividends. The company's solid performance supports its ability to maintain a competitive dividend yield, making it an appealing choice for income-seeking investors.
Additionally, its investments in digital healthcare and lab technology strengthen its market position. As demand for healthcare services rises, particularly in areas like personalized medicine & aging populations, Quest is well-positioned to capitalize on these trends, making it a promising dividend stock for long-term growth.
@Tiger_Earnings @Tiger_comments @TigerStars @TigerGPT
๐